Oncology Data Advisor

In honor of Rare Disease Day on February 28, Oncology Data Advisor spoke with Amy DeZern, MD, MHS, Director of the Bone Marrow Failure and Myelodysplastic Syndromes (MDS) Program at Johns Hopkins Medicine and member of the Aplastic Anemia and MDS International Foundation (AAMDSIF) medical advisory board. In this interview, Dr. DeZern explains the challenges of treating such a rare disease and shares some of recent promising updates in novel treatments for patients with MDS.

In honor of World Cancer Day, members of the Oncology Data Advisor (ODA) editorial board gathered to discuss the latest advances and future directions in oncology research. Dr. Thomas Abrams, an Assistant Professor of Medicine at Harvard Medical School shared recent progress in the field of gastrointestinal cancers; Dr. Ulka Vaishampayan, a Professor of Internal Medicine at the University of Michigan Rogel Cancer Center provided insights into current trends in genitourinary cancer research; and Beth Sandy, MSN, CRNP, an outpatient thoracic oncology nurse practitioner at the University of Pennsylvania Abramson Cancer Center, discussed recent and future treatment advances in the field of lung cancer.

Dr. Rahul Banerjee and Dr. Kelly Brassil discuss the design of an ongoing phase 2 trial investigating digital life coaching and its implications for improving the quality of life of patients undergoing ASCT for multiple myeloma.

In this interview, Dr. Thomas Abrams of Harvard Medical School discusses the role that cabozantinib/atezolizumab may play for patients with metastatic colorectal cancer, particularly those with RAS wild-type disease, in the coming years.

Tumor suppressor gene p53 is the most frequently mutated gene in human malignancy. Through a complex series of molecular events, p53 leads to malignant cell proliferation and plays a significant role in tumor formation. In this interview with Oncology Data Advisor, Dr. Matthew Davids of Harvard Medical School delves further into the latest research in p53-directed therapeutic strategies and the future of targeting this specific mutation.

Although survival in childhood acute lymphoblastic leukemia (ALL) has improved over the years, there remains a need to identify racial, ethnic, and socioeconomic health disparities that contribute to poor outcomes. In this interview, Dr. Sumit Gupta explains the importance of recognizing health disparities among pediatric patients with ALL and the changes that can be implemented to address them.

Over recent years, numerous developments have occurred in the fields of breast cancer prevention, genetic testing, screening, and surgical procedures. In this interview, Dr. Brigid Killelea, Medical Director of Breast Surgery at Hartford HealthCare, explains strategies for incorporating these advances into the care of patients with breast cancer.

Significant progress has been made in numerous facets of breast cancer care in recent years, including developments in treatment, imaging, pathology, radiation, and surgery. In this interview, Dr. Richard Zelkowitz, a Regional Medical Director of the Breast Program at Hartford HealthCare, highlights the advances that have been made and explains the importance of subspecialties in ensuring that patients with breast cancer receive the most individualized care possible.

For patients with breast cancer, the approach to treatment requires an individualized approach accounting for factors such as genetic risk, symptom management, and more recently, the challenges of the COVID-19 pandemic. In this interview, Dr. Valerie Brutus, a breast surgical oncologist at St. Vincent’s Medical Center of Hartford HealthCare, discusses strategies for successfully incorporating each of these factors into patients’ treatment.

In this recording of Oncology Data Advisor’s Live Breast Cancer Panel, three noted experts in breast cancer management partake in a conversation about recent advances in treatment, strategies and integrative medicine modalities to minimize toxicity, and techniques for enabling patients with breast cancer to thrive throughout their diagnosis and treatment.

How can members of the cancer care team enable breast cancer survivors to become breast cancer thrivers? Watch as Lillie Shockney, RN, BS, MAS, HON-ONN-CG, Professor of Surgery at Johns Hopkins University and member of the National Breast Cancer Foundation medical advisory council, explains how to provide optimal care and support for patients with breast cancer during their treatment and beyond.

Although the management of breast cancer has been impacted by the COVID-19 pandemic, the cancer care team has developed strategies to optimize screening and treatment experiences in spite of these challenges. In this podcast, Lillie Shockney, RN, BS, MAS, HON-ONN-CG, Professor of Surgery at Johns Hopkins University and member of the National Breast Cancer Foundation medical advisory council, shares advice advice regarding protocols for undergoing mammograms during the pandemic, including the timing of COVID-19 vaccination.

This podcast interview features Erin Prendergast, RN, CBCN®, an oncology nurse navigator and Senior Breast Clinical Coordinator in the Breast Cancer Program at UT Southwestern Simmons Comprehensive Cancer Center. Ms. Prendergast explains what she does in her role as an oncology nurse navigator and shares strategies that her team has implemented to ensure that patients with breast cancer receive optimal access to treatment and supportive care during the COVID-19 pandemic.

How can members of the cancer care team help their patients with breast cancer continue to thrive despite their diagnosis? Watch as Lillie Shockney, RN, BS, MAS, HON-ONN-CG, Professor of Surgery at Johns Hopkins University and member of the National Breast Cancer Foundation medical advisory council, shares how to enhance quality of life preservation and restoration for breast cancer patients and survivors.

For this podcast in honor of Breast Cancer Awareness Month, Lillie Shockney, RN, BS, MAS, HON-ONN-CG, Professor of Surgery at Johns Hopkins University and member of the National Breast Cancer Foundation medical advisory council, discusses current standards and recent advances in breast cancer surgery, including lumpectomies, prophylactic mastectomies, and reconstructive procedures.

In this interview, in honor of Breast Cancer Awareness Month, Tricia Trammell, BA, CRA, FAHRA, R.T. (R)(M)(QM)(BS), CN-BI, Breast Center Manager at UT Southwestern Simmons Comprehensive Cancer Center, discusses the advancements in breast imaging in relation to screening for breast cancer.

In this interview in honor of Breast Cancer Awareness Month, Judy Herrick, RN, OCN®, ONN-CG, the Supervisor of Support Services at UT Southwestern Simmons Comprehensive Cancer Center, discusses the role of oncology nurse navigation and support services in ensuring that patients with breast cancer receive optimal care during their treatment. Ms. Herrick also discusses the importance of patient education and shares strategies for utilizing available resources to address all facets of breast cancer care.

In this interview, Lillie Shockney, RN, BS, MAS, HON-ONN-CG, Professor of Surgery at Johns Hopkins University and medical advisory council member of the National Breast Cancer Foundation, discusses the pathology of breast cancer, prognostic factors for disease outcomes, and the crucial role of breast pathologists in setting the stage for diagnosis and treatment.

In her latest Breast Cancer Awareness Month video, Lillie Shockney, RN, BS, MAS, HON-ONN-CG, Professor of Surgery at Johns Hopkins University and member of the National Breast Cancer Foundation medical advisory council, discusses the importance of undergoing 3D mammography breast cancer screening, as well as the crucial role of breast imaging radiologists in this field.

In honor of prostate cancer awareness month, Dr. Ulka Vaishampayan, will be discussing issues surrounding prostate cancer.